Anzeige
Mehr »
Login
Samstag, 15.08.2020 Börsentäglich über 12.000 News von 645 internationalen Medien
Alle Erwartungen übertroffen! Kursexplosion am Montag!?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrUNION therapeutics to acquire licence for Covid-19 technologies developed by TFF Pharmaceuticals
FrFDA accepts Enzychem's IND for trial of Covid-19 treatment candidate
DoBlade Therapeutics updates enrolment progress for Covid-19 pneumonia study of BLD-2660
DoInPedILD trial enrols first patient to evaluate nintedanib in pediatric population with fibrosing ILD
DoGeneCentric, Janssen collaborate to study genomic drug response biomarkers for NMIBC
MiModerna announces supply agreement with US Government for initial 100 million doses of mRNA vaccine against Covid-19
MiCheckMate -577 trial for Opdivo meets primary endpoint of disease-free survival
MiSAB begins phase 1 trial of Covid-19 therapeutic candidate SAB-185
MiBayer to buy UK biotech company KaNDy Therapeutics
DiFDA clears Appili Therapeutics to expand its trial of favipiravir for prrevention of Covid-19
DiOmeros reports positive results for Narsoplimab in treatment of Covid-19-associated ARDS
DiGilead seeks FDA approval for Veklury in Covid-19 treatment
DiLigand Pharmaceuticals to buy Pfenex for up to $516m
MoPfizer announces agreement with Gilead to manufacture Remdesivir to treat Covid-19
MoUS FDA approves Lampit for the treatment of Chagas disease in children
MoTakeda to license Novavax' Covid-19 vaccine candidate NVX-CoV2373
MoRoche gets FDA nod for Evrysdi to treat spinal muscular atrophy
07.08.Daiichi Sankyo, AstraZeneca collaborate to evaluate patritumab deruxtecan in combination with TAGRISSO in EGFR-mutated NSCLC
07.08.ViiV Healthcare gets FDA expanded approval for HIV-1 drug Dovato
06.08.J&J announces agreement with US govt for 100 million doses of investigational Covid-19 vaccine
06.08.LORBRENA significantly improves progression-free survival in first-line ALK-positive lung cancer
06.08.GSK secures FDA nod for BLENREP to treat relapsed or refractory multiple myeloma
05.08.Seismic Bio partners with Twist Bioscience for discovery and optimisation of antibodies
05.08.RLF-100 shown to deliver rapid recovery from respiratory failure in Covid-19 patients
05.08.MYR Pharmaceuticals receives conditional marketing authorisation by European Commission for HEPCLUDEX